Associate Professor Warren Rose’s atypical approach to overcoming antibiotic resistance receives more national recognition.

Associate Professor Warren Rose’s atypical approach to overcoming antibiotic resistance receives more national recognition.
A survey of how 132 hospitals prescribed six new antibiotics from 2014 to 2018 found that the average time to prescribe any one of the new drugs was 398 days.
With a new R01 grant from the National Institutes of Health, Associate Professor Warren Rose is testing a MRSA subset that might not be as resistant to beta-lactams as previously thought.
Associate Professor Warren Rose’s new research collaboration with UW Health examines the effectiveness of a new antibiotic.
Associate Professor Warren Rose’s commitment to exploring new treatments for infectious diseases is earning him national recognition.
A record number of the School of Pharmacy’s PharmD students present their research at the 2018 ACCP Global Conference.
Associate Professor Warren Rose is being honored by the American College of Clinical Pharmacy for his years of innovative research and contributions to his field.
As part of a top-tier research university, the UW–Madison School of Pharmacy offers PharmD students substantive research exposure across various research areas.
By showing where in the state resistance to particular drugs is highest, School of Pharmacy researchers aim to give physicians the tools they need to quickly and accurately choose the best antibiotic.
School’s undergrad Pharmacology-Toxicology program offers broad research opportunities from exploring fish endocrinology to fighting antibiotic resistance.